Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tradipitant in Gastroparesis
NCT04028492Phase 3Completed
- Sponsor
- Vanda Pharmaceuticals Inc.
- Start
- Aug 2019
- Primary completion
- Feb 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of tradipitant in gastroparesis, sponsored by Vanda Pharmaceuticals Inc.. Started Aug 2019; status: completed.
02
Drugs
tradipitant
03
Conditions
gastroparesis
Beyond the preview
Go deeper on NCT04028492.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04028492.